. DNA Damage Disperses BRCA1 S Phase Focal Staining S phase MCF7 cells were treated with DNA damaging agents, as indicated. Immunostaining for BRCA1 was performed using mAb MS13. Cells received either no treatment, HU 1 mM, UV 10 Jm Ϫ2 , or 5000 Rads and were harvested 1 hr later. The arrow indicates a Figure 2 . Specific Phosphorylation of BRCA1 following DNA rare cell in an HU-treated culture which retains some focal staining Damage for BRCA1.
(A) Cell cycle variation in BRCA1 gel mobility. MCF7 extracts were immunoblotted for BRCA1 using mAb MS110. Migration of BRCA1 is indicated. Async, asynchronous culture (58% G1, 30% S); starved, cells after 24 hr of serum starvation (90% G1, 2.5% S); G1, cells 12 hr after release into high serum (86% G1, 7% S); S ϩ Nil, cells 24 multiple cell lines during G1, when a less intense nucleohr after release into high serum (40% G1, 54% S); S ϩ HU, identically plasmic BRCA1 immunostaining signal was observed treated S phase cells (in parallel) cultured after 24 hr of serum refeed- (Scully et al., 1997a) . They can be detected using many ing in HU for 1 hr before harvesting.
different BRCA1-specific Abs, raised to distinct epi- (B) Changes in mobility are due to changes in phosphorylation of topes, using any of several different fixation methods, BRCA1 . BRCA1 IPs were treated with -phosphatase (see Experi- or in living cells containing green fluorescent protein mental Procedures) Ϯ phosphatase inhibitors, as indicated, and then immunoblotted for BRCA1. IVT, in vitro translated wild-type (GFP)-tagged BRCA1 (Scully et al., 1996 ; R. S., D. M. L., performed with any of three different BRCA1 monoclonal antibodies, revealed overt dispersal of BRCA1 nuclear foci ( Figure 1 ). Given the likelihood that HU treatment of S phase cells mimics DNA damage (Allen et al., 1994; (e.g., cell indicated by an arrow in Figure 1 ). The nature of these foci is discussed below (Figures 5 and 6 and Carr, 1995; Sanchez et al., 1996; Sun et al., 1996) , we asked whether other DNA damaging agents affect the accompanying text). integrity of the S phase BRCA1 dots. Treatment with ultraviolet (UV) irradiation, mitomycin C, or gamma irraCell Cycle-Specific Phosphorylation of BRCA1 In an effort to understand the mechanisms governing diation also led to dispersal of the dots within 1 hr ( Figure  1 and data not shown). Untreated or mock-treated S the migration of BRCA1 into and out of S phase foci, we sought biochemical correlates of the different BRCA1 phase cells revealed typical BRCA1 dots (Figure 1 and data not shown). Thus, dispersal of BRCA1 S phase foci nuclear immunofluorescence patterns. Immunoblotting for p220 BRCA1 in asynchronous MCF7 cells revealed might represent a cellular response to DNA damage. A few cells retained BRCA1 foci after HU or UV treatment a doublet (Figure 2A ). Each band of the doublet reacted with BRCA1 monoclonal antibodies (mAbs), MS13, migration of the S phase BRCA1 band, similar to the effect of HU treatment ( Figure 2C ). This effect, coupled MS110, SG11, and AP16 (data not shown and Figure 2B ). Serum-starved MCF7 cells contained reduced levels of with the above noted dispersal of BRCA1 S phase foci (Figure 1 ), indicated a similarity between the effect of BRCA1 (Figure 2A ). Cells released into G1 for 12 hr produced an enrichment of the faster migrating band of these DNA damaging agents and HU. However, in contrast to HU-treated cells, the response of S phase cells the doublet (Figure 2A ). In contrast, 24 hr after release into high serum, when most cells were in S phase, there to two of these three DNA damaging agents did not include acute DNA synthesis arrest. Specifically, mitowas a further increase in BRCA1 protein level, represented primarily by the slower migrating form of the mycin C-treated and gamma-irradiated S phase MCF7 cells showed no impairment of BrdU incorporation comprotein ( Figure 2A ). Similar observations concerning the migration of G1 and S phase associated forms of BRCA1 pared with untreated controls, at a time when BRCA1 had already undergone the relevant DNA damagehave been made by Ruffner and Verma (1997) .
A parallel culture of S phase MCF7 cells was treated induced phosphorylation ( Figures 2C and 2D ). UV treatment led to a dose-dependent inhibition of BrdU uptake, with HU for 1 hr. Immunoblotting revealed the presence of a form of BRCA1 that was not detected in untreated with only a modest impairment of DNA synthesis detectable in cells treated with 10 Jm
Ϫ2
, but near total DNA cycling cells but which migrated more slowly than the BRCA1 present in untreated S phase cells (Figure 2A ).
synthesis arrest seen at 50 Jm Ϫ2 ( Figure 2D and data not shown). Ten joules per square meter did, however, Thus, endogenous ''p220'' BRCA1 was detectable in at least three different forms: a rapidly migrating, G1-lead to the supershift of the S phase band, as seen following treatment with HU, mitomycin, or gamma irraassociated form; a more slowly migrating, S phase form; and an even more slowly migrating form, noted in HUdiation ( Figure 2C ). The finding of continued BrdU incorporation into S treated S phase cells.
Thus, BRCA1 might undergo regulated post-translaphase cells that had sustained acute DNA damage could be interpreted as unscheduled DNA synthesis (i.e., retional modifications, such as phosphorylation. Consistent with this, phosphatase treatment of BRCA1 immupair synthesis) in the context of an arrest of scheduled DNA synthesis. Although some repair process might be noprecipitates (IPs) altered the gel mobility of BRCA1 ( Figure 2B ). IPs of BRCA1 from asynchronous MCF7 expected to be occurring at this time (e.g., to permit resolution of abnormal DNA structures at replication cells, using the C-terminal mAb, SG11, were aliquoted into three fractions. The first was treated with -phosforks), the data are incompatible with the idea that scheduled DNA synthesis itself had ceased. First, BrdU phatase in the presence of phosphatase inhibitors; the second with -phosphatase in the absence of inhibitors; incorporation during repair synthesis should be much less efficient than during normal DNA replication (Li et and the third was left untreated. IPs were immunoblotted using the N-terminal BRCA1 mAb, MS110. Phosphatase al., 1996) , whereas near normal DNA synthesis levels were noted after acute exposure to mitomycin C, gamma treatment in the absence of inhibitors resulted in collapse of the BRCA1 doublet into a single band which irradiation, or 10 Jm Ϫ2 UV. Second, if the BrdU incorporation detected were a manifestation of repair synthesis comigrated with in vitro synthesized, clonal BRCA1 (Figure 2B ). Phosphatase treatment in the presence of inhibalone, a higher density of DNA lesions should produce a higher level of BrdU incorporation. However, the reverse itors did not perturb the BRCA1 doublet relative to untreated IPs ( Figure 2B ), ruling out nonspecific effects was true for UV treatment, where increasing doses led to progressive impairment of BrdU incorporation effiof the phosphatase preparation. Similarly, phosphatase treatment of BRCA1 IPs, prepared from HU-treated S ciency. Therefore, 1 hr after treatment with either UV irradiation (10 Jm
), mitomycin C, or gamma irradiation, phase cells, led to its comigration with the phosphatasetreated BRCA1 species detected in naive S phase cells scheduled DNA synthesis had not yet ceased. Therefore, DNA damage-associated BRCA1 phosphorylation ( Figure 2B ). These results strongly suggest that the differential gel mobility of the three forms of BRCA1, noted can occur in S phase cells without arrest of scheduled DNA synthesis. in G1, S phase, and HU-treated S phase cells, is due to differential phosphorylation.
Although three DNA damaging agents and HU had disparate effects upon scheduled DNA synthesis, the HU treatment of S phase cells, therefore, led to three measured events: DNA synthesis arrest, dispersal of feature common to all these treatments is their ability to induce DNA lesions, rather than their effect on the BRCA1 foci, and phosphorylation of BRCA1. DNA synthesis arrest following brief (2 hr) HU exposure was replication machinery per se. HU treatment might be predicted to produce, at least transiently, ''abnormal'' found to be reversible. Removal of HU after this time led to the resumption of full DNA synthesis. Furthermore, (i.e., nonduplex) DNA structures at arrested replication both the BRCA1 foci and the faster migrating S phase forks. The simplest model to explain these phenomena BRCA1 band reappeared, while the slower HU-associwould be one in which ''abnormal'' DNA structures, genated band disappeared (data not shown). Therefore, erated in S phase, trigger a signaling cascade, one outwithin the time limits of this experiment, all three effects come of which is specific BRCA1 phosphorylation. of HU were reversible.
Time Course of the Response to UV Irradiation Phosphorylation of BRCA1 after DNA
These results suggest a relationship between DNA damDamage in S Phase without Arrest age-associated phosphorylation of BRCA1 and disof Scheduled DNA Synthesis persal of the BRCA1 dots. This was explored further, Exposure of S phase MCF7 cells to UV irradiation, mitomycin C, or gamma irradiation was found to retard the using UV as the stimulus. The phosphorylation status of BRCA1 was followed at 10-min intervals following a pulse of 10 Jm
Ϫ2
, administered to S phase MCF7 cells. A significant alteration in BRCA1 gel mobility was apparent 20-30 min after treatment ( Figure 3A) . In a similar experiment, the time course of dispersal of BRCA1 foci was followed at 5-min intervals, by scoring, at each time point, four randomly selected confocal microscopic fields for the percentage of cells containing BRCA1 foci. Significant dispersal of BRCA1 foci was not detected until 25 min after the UV pulse ( Figure 3B ). Thus, at this UV dose (and also at higher doses, data not shown), there was a close temporal correlation between damage-induced phosphorylation of BRCA1 and dispersal of the BRCA1 foci.
Hydroxyurea, Mitomycin C, and UV Treatments Preferentially Target BRCA1 in S Phase
The data, noted above, raise the question of whether BRCA1 is targeted for phosphorylation by DNA damage only in S phase. The migration pattern of MCF7 in asynchronous or G1-enriched cells provided a means to address this question. We had noted ( Figure 2A ) that there is a faster migrating form of p220 BRCA1 enriched in G1 MCF7 cells and detectable in asynchronous cultures. Asynchronous MCF7 cells were subjected to treatment Figures 2C and 3C ). Higher doses of nously growing MCF7 cells were exposed to metered doses of UV led to a dose-dependent shift in the G1 form of gamma irradiation, harvested 1 hr later, and then immunoblotted BRCA1 ( Figure 3C ) as did gamma irradiation (5000 for BRCA1. The lower (G1) band of BRCA1, indicated with an arrow, was noted to disappear at 50 Rads, whereas the S phase band Rads).
shifted only at doses above 200 Rads.
This preferential S phase targeting of BRCA1 for phosphorylation, following HU, low dose UV, or mitomycin C, could be interpreted in two ways. First, the sensor(s) of abnormal DNA structure, or their subsequent amplifigamma irradiation. When asynchronous MCF7 cells were exposed to a range of doses of gamma irradiation, catory cascades, might operate differently between S phase and G1. Second, the S phase preference for the emergence of BRCA1 species migrating slower than the S phase band was apparent only at doses above BRCA1 phosphorylation after UV/mitomycin C could be an attribute of the BRCA1 protein itself, rather than of 200 Rads ( Figure 3D ). In contrast, exposure to 50 Rads was sufficient to displace the G1 form of the protein the signals impinging on it. A hint that the former might be correct came from examination of the response to ( Figure 3D ). Therefore, gamma irradiation appeared to shown). Immunoblotting of whole cell extracts was used to confirm the expression of p460 DNA-PK in MO59K cells and its absence from MO59J cells ( Figure 4A ). BRCA1 phosphorylation after HU or UV treatment was also detected in both cell lines, and the response to each of these stimuli was indistinguishable between MO59J and MO59K cells (data not shown). These results exclude p460 DNA-PK as a necessary component of the DNA damage-BRCA1 phosphorylation pathway.
To investigate a potential role for Atm, we analyzed primary cultures of Atm homozygous mutant fibroblasts. Both HU and UV exposure elicited a clear retardation in the migration of the S phase BRCA1 band ( Figure 4B) . A similar response to gamma irradiation was also noted (data not shown), although a quantitative effect of Atm on the DNA damage-BRCA1 signaling pathway has not yet been ruled out.
Recruitment of BRCA1 to PCNA-and DNAContaining Nuclear Structures after DNA Damage in S Phase
Close examination of the BRCA1 immunostaining pat- was not zero (Figures 1 and 3B) . In a small proportion of BRCA1 and proliferating cell nuclear antigen (PCNA), as detailed below.
Under some fixation conditions, PCNA immunostainprovide an exception to the above-noted preference for S phase in signaling from DNA damage to BRCA1. This ing is seen only in cells synthesizing DNA, and given that its staining pattern changes during S phase, it can suggests that cell cycle specificity in the BRCA1 DNA damage response is a property of the particular sensors be used as an S phase temporal marker (Bravo, 1986; Bravo and Macdonald-Bravo, 1987) . In early/mid-S of and signaling arising from DNA damage, rather than of the BRCA1 protein itself.
phase cells, PCNA immunostaining is in a multifocal/ diffusely nuclear pattern. In late S phase, the staining pattern changes dramatically and becomes ''nodular.'' DNA-Dependent Protein Kinase and the Ataxia Telangiectasia Gene Product Are Not Required Importantly, throughout S phase, the immunostaining pattern of BrdU incorporation into replication forks for DNA Damage-Induced BRCA1 Phosphorylation in S Phase clearly overlies the PCNA stain (Bravo and MacdonaldBravo, 1987; Nakamura et al., 1986 ; Figure 5A ). We conGenetic and biochemical approaches suggest a role for the PIK family of nuclear protein kinases in linking the firmed, by the use of a mimosine block and release protocol, that these changes in PCNA morphology are detection of DNA damage to cell cycle responses (Bentley et al., 1996; Cimprich et al., 1996; Hari et al., 1995;  similarly correlated with the stage of S phase in MCF7 cells (data not shown). Hartley et al., 1995; Morrow et al., 1995; Savitsky et al., 1995) . This family of proteins
In synchronized cells, BRCA1 foci first appear in S phase. This raised the question of whether BRCA1 foci includes the catalytic subunit of DNA-dependent protein kinase (p460 DNA-PK), Atm, and Atr. Initially, we asked coincide with PCNA foci. This was addressed using twocolor immunostaining followed by confocal microscopy. whether a functional copy of DNA-PK was necessary for detection of the BRCA1 DNA damage-phosphorylation Images in Figure 5B depict unperturbed, S phase MCF7 cells doubly stained for BRCA1 (green, fluorescein isoresponse. The human glioma cell line, MO59, has two derivatives, one of which (MO59K) is wild-type for p460 thiocyanate [FITC] ) and PCNA (red, rhodamine). In repeated experiments, the two immunostaining patterns DNA-PK. The other (MO59J) does not express its gene (Lees-Miller et al., 1995) . Using gamma irradiation as the were found to be distinct, even when the PCNA pattern resembled the nodular one reported for late S phase stimulus, we asked whether the two cell lines could each respond to DNA damage by phosphorylating BRCA1.
cells (Bravo and Macdonald-Bravo, 1987; Nakamura et al., 1986) . Thus, in conventionally cycling S phase cells, Indeed, the two cell lines mounted indistinguishable responses to gamma irradiation ( Figure 4A and data not there was no immunocytochemical indication that BRCA1 focally accumulates at replication forks. Further, HU or UV treatment of S phase cells. By contrast, the small subset of nuclei scoring positive for BRCA1 dots a small proportion of cells was noted to be positive for BRCA1 foci and negative for PCNA. This population was but negative for PCNA (presumed G2 cells, as noted above) were not perturbed by either HU or UV treatment found to be enriched in late S phase cultures (data not shown), suggesting that the presence of BRCA1 foci is (e.g., ''UV ϩ '' panel in Figure 5B , cell indicated by an arrow). also a feature of some G2 cells.
In contrast, when HU-or UV-treated S phase cultures were similarly examined, a striking colocalization of the Colocalization of BRCA1, BARD1, and Rad51 before and after DNA Damage in S Phase BRCA1 staining pattern and the PCNA staining pattern was noted in those rare, late S phase cells in which PCNA Two proteins associated with BRCA1 in S phase fociRad51 and BARD1-were examined during the DNA immunostaining was clearly nodular or focal ( Figure 5B and data not shown). In the majority of S phase nuclei, damage response. Consistent with the described physical interaction between BRCA1 and BARD1 (Wu et al., where the PCNA pattern was diffuse, the BRCA1 stain was also diffuse (data not shown). The overt relocation 1996), BARD1 immunostaining, reflected by binding of multiple antibodies to BARD1, colocalized with BRCA1 of BRCA1 to PCNA ϩ structures after DNA damage suggests that BRCA1 is recruited to replication forks after in S phase nuclear dots ( Figure 6A ). This result was . Cells were double stained for Rad51 (using affinity purified polyclonal antiserum to Rad51, green) and PCNA (using ''AK'' antiserum, red), as described in Experimental Procedures. After HU treatment (''HUϩ''), but not in untreated cells (''HUϪ''), significant colocalization of Rad51 and PCNA is seen as a yellow overlap.
first obtained by Richard Baer and coworkers (personal the BARD1/Rad51 G2 foci were not perturbed by either UV or HU treatment (data not shown). communication). S phase (PCNA ϩ ) nuclei were examThese findings strengthen the notion that BRCA1 reloined for BARD1 and Rad51 before and after HU or UV calizes to replication forks after DNA damage, since it treatment. As was noted for BRCA1, undamaged cells does so in the company of two known physiological revealed no significant colocalization of either Rad51 or partners. Hence, either multiprotein BRCA1-containing BARD1 with PCNA ( Figures 6B and 6C, see HUϪ) . After complexes leave the dots after DNA damage, or the HU or UV exposure, however, colocalization was seen underlying subnuclear structure which constitutes the on PCNA nodules (Figures 6B and 6C, see HUϩ) . In the substance of the S phase foci, itself, undergoes disasmajority of S phase nuclei, where the PCNA stain was sembly after DNA damage. diffuse, Rad51 and BARD1 stains were also found to have become diffuse (data not shown). Thus, BRCA1 and two known associated proteins, BARD1 and Rad51, Discussion both concentrate in PCNA-containing, replicating structures after DNA damage. Like BRCA1 dots, BARD1 and These experiments identify the p220 BRCA1 protein as Rad51 foci appeared to persist into G2 (data not shown).
a participant in a DNA damage response of cycling cells, thereby fulfilling the prediction that BRCA1 participates In addition, as was noted above for BRCA1 foci in G2, in the maintenance of genome integrity (Scully et al., and Young, 1980; reviewed in Elledge, 1996 1995) . DNA-PK functions in double-stranded break repair and VDJ recombination (reviewed in Lieber et al., tein underwent a specific change(s) in phosphorylation. Third, BRCA1 was now associated with PCNA/replicat-1997). In addition, the products of these genes are protein kinases and they interact with yet other protein ing DNA-containing structures. The timing of these events was closely correlated, suggesting that they are kinases. This combined evidence suggests that the ''PIK'' kinases are signal transducers, e.g., linking DNA different manifestations of the same cellular response. Taken together, these findings allow one to construct a damage with cell cycle events (reviewed in Elledge, 1996) . Our observations on BRCA1 suggest that its functional model of BRCA1 behavior, at least during S phase.
phosphorylation after DNA damage might be an assay for the activity of one or more ''PIK'' kinases. There are First, the BRCA1 dots, which clearly contain BRCA1-containing complexes, given the colocalization of both data in the literature consistent with a model in which BRCA1 and Atr and, possibly, Atm interact on meiotic Rad51 and BARD1, appear to be dynamic physiological structures. Their integrity is, at a minimum, tied to the chromosomes (Keegan et al., 1996; Scully et al., 1997a) . The availability of tissue from ataxia-telangiectasia integrity of the genome. DNA damage leads to signals, transmitted over a measurable period of time, which patients has provided cultured primary cells lacking Atm function. For each modality of DNA damage examresult in the loss of BRCA1 containing protein/protein complexes from these structures, if not the loss of the ined-HU treatment, UV, or ionizing radiation-S phase BRCA1 mobility slowed within 1 hr of exposure. Thus, structures themselves. These signals do not depend upon the cessation of DNA synthesis for accurate transAtm is not absolutely required for S phase DNA damageinduced phosphorylation of BRCA1. Whether the same mission and are, hence, not a specific result of replication arrest. Whether the dots are active in the absence is true for G1 cells is unclear at present. Similarly, p460 DNA-PK deficient cells responded normally to this same of genome damage, playing an as yet unknown role in the replication process (and/or in postreplication events) spectrum of DNA damaging agents. This implies that DNA-PK is not an absolute requirement for the S phase or whether they are simply repositories of proteins that are active in the damage (and possibly other stress) effect as well. The components of the S phase DNA damage/BRCA1 signaling pathway, therefore, remain to response(s) is not clear. That BRCA1 appears to disperse from the dots after genome damage strongly sugbe identified. Based upon what is known from analyses of Drosophila and yeast, Atr must be considered a pogests that BRCA1 itself plays a role in the response to DNA damage. Such a conclusion strongly supports the tential participant in this pathway. At present, however, there are no cell lines known to be functionally null for earlier speculation put forward on the occasion of the first detection of BRCA1/Rad 51 complexes (Scully et Atr.
Finally, BRCA1 appears to relocalize to replicating al., 1997a). Thus, the BRCA1/Rad51/BARD1 nuclear dots are an example of multiprotein-containing nuclear DNA structures after DNA damage. The interpretation of these observations can only be speculated upon at structures whose integrity is modified by modifiers of genome integrity.
present. HU and UV induced the same relocalization behavior in BRCA1 (also in Rad51 and BARD1), again Second, in parallel with the loss of the BRCA1 dots, DNA damage led to a specific alteration in the state of suggesting that the responses provoked by these two agents have fundamental similarities. One interpretation BRCA1 phosphorylation. The timing of the two events was similar, and both events were reversible in HUof these phenomena is that, in each case, a DNA repair process is initiated at the replication fork. In the case treated cells, implying that they are linked and that both are reflections of the existence of unrepaired DNA damof UV-induced damage, DNA replication may be accompanied by a recombinational DNA damage response age. These findings indicate that BRCA1 is a substrate of one or more kinases activated specifically by DNA (Fornace, 1983; Friedberg et al., 1995) . In the case of HU treatment, the replication fork likely contains a high damage. They, therefore, place BRCA1 on an S phase DNA damage-initiated signaling pathway. G1 cells were density of ''abnormal,'' or nonduplex, DNA structures, which might provoke a DNA damage response. If such able to respond with specific BRCA1 phosphorylation events following DNA damage, but there were clear difspeculations hold true, one might deduce that BRCA1 has an affinity for sites of specialized DNA structure, ferences in the substance of the responses between G1 and S phase cells. Whether the protein contributes to the a conclusion supported by its localization to the axial element of the developing synaptonemal complex enaction of both G1 and S (and possibly G2) checkpoint responses remains to be seen. (Kleckner, 1996; Scully et al., 1997a) . If BRCA1 is recruited to certain abnormal DNA strucOne class of genes implicated in such signaling pathways encode the ''PIK'' kinases, Atm, Atr, and p460 tures as part of a DNA damage response, a role for BRCA1 in DNA repair seems likely. This might or might DNA-PK, each of which shows extensive conservation between yeast, drosophila and human (Bentley et al., not be linked to an inferred role of BRCA1 in transcription regulation, as evidenced by its transactivation domain 1996; Cimprich et al., 1996; Hari et al., 1995; Hartley et al., 1995; Morrow et al., 1995;  and by its stable association with the RNA polymerase II holoenzyme (Scully et al., 1997b) . Two paradigms, Savitsky et al., 1995) . Genetic analysis has suggested a role for Atm in multiple cell cycle checkpoints (Painter which are not mutually exclusive, could be considered.
(Amersham). IP of BRCA1 was performed as described previously First, BRCA1 may play a DNA repair role, even in the (Scully et al., 1997a Bhatia et al., 1996) . Second, BRCA1 may be truly bifunc- heating samples to 30ЊC for 1 min, 500 U of -phosphatase (New tumor suppressor protein likely operates in such a biEngland Biolabs) was added to each sample, followed by incubation functional manner (reviewed in Ko and Prives, 1996) .
at 30ЊC for 1 hr. Samples were separated by SDS-PAGE and immuHow do these observations reflect upon the function noblotted for BRCA1. In the same experiments, in vitro translation of the BRCA1 cDNA was performed using a TNT kit (Promega Similarly obscure at present is the relationship that Triton buffer (above) prior to paraformaldehyde fixation, to elute away the soluble PCNA fraction (a modification of Li et al., 1996) .
might exist between the mechanisms governing the be-BRCA1 was visualized using mAbs-MS13, MS110, or AP16 (Scully havior of BRCA1 in a replication checkpoint pathway et al., 1996) . PCNA was visualized using AK antiserum at 1:5000, or and the tissue specificity of its role in tumor suppression.
with PCNA mAb PC10 (Santa Cruz) at 1:100. BARD1 was visualized
The connection may become clearer from a better unusing an affinity-purified rabbit polyclonal antiserum to residues derstanding of the biology of breast and ovarian epi-141-388 of the gene product. This was shown to colocalize with thelium.
BARD1-specific mAbs, confirming the identity of the signal. Crossreactivity between this antiserum and BRCA1 protein was sought but not detected. Rad51 Ab was generated by immunization of Experimental Procedures rabbits with GST-Rad51 fusion protein. After absorption of anti-GST Abs, affinity purification was performed by standard methods using Tissue Culture Methods an aminolink column (Pierce) coupled to GST-Rad51. All secondary Cells were cultured in Dulbecco's modified Eagle's medium antibodies used were species-specific fluorochrome-conjugated (DMEM)-10% fetal bovine serum (FBS). MCF7 cells were synchroAbs from Jackson Immunoresearch, used at 1:200 throughout. nized as described previously (Scully et al., 1997a) . For late G1 Two-color immunostaining for BrdU and PCNA was performed synchronization, mimosine (200 M final concentration) was added as follows. Methanol-acetone fixed cells were stained with PCNA to MCF7 cells for 16 hr. Release into S phase produced tight synantiserum ''AK'' (from R. Ochs), followed by secondary Ab. After chrony through this segment of the cycle, allowing preparation of post-fixing in paraformaldehyde/sucrose solution (above) for 10 min early or late S phase cultures.
at room temperature, cells were incubated for 5 min in 2 N HCl to expose incorporated BrdU. After multiple phosphate-buffered saline (PBS) washes, fluorescein isothiocyanate (FITC)-conjugated anti-
DNA Damaging Agents
BrdU mAb (Becton Dickenson) was used to develop a BrdU incorpoCells were exposed to genotoxic agents and, unless otherwise ration signal. stated, harvested 1 hr later. HU (Sigma) treatment was added to a All antibody incubations were performed at 37ЊC for 20 min. Under final concentration of 1 mM. Mitomycin C (Sigma) was added to a the conditions used, no significant signal attributable to secondary final concentration of 20 g/ml. UV doses were delivered in a single antibody, alone, was detected. All images were collected by confopulse using a Stratalinker (Stratagene). Prior to pulsing, medium cal microscopy (Zeiss) and processed using Adobe Photoshop was removed, being replaced immediately after treatment. Gamma software. irradiation was delivered using a Gammacell 1000 apparatus.
Cell Cycle Analysis Immunoblotting and Immunoprecipitation of BRCA1
Cells were pulsed with BrdU (Boehringer-Mannheim) for 10 min Cell extracts were prepared in EBC buffer (50 mM Tris, pH 8, 120 prior to harvesting. Aliquots of harvested plates were trypsinized, mM NaCl, 0.5% Nonidet P-40 , with the addition of 50 mM neutralized, washed in PBS, and fixed in cold 70% ethanol while NaF, 1 mM sodium orthovanadate, 100 g/ml polymethylsulfonyl vortexing. After storage on ice, cells were vortexed into 2 N HCl/ fluoride (PMSF), 20 g/ml aprotinin, and 10 g/ml leupeptin. One 0.5% Tween-20. After 30 min of incubation, cells were washed twice hundred micrograms of whole cell extract were loaded per lane. To in PBS/HEPES, pH 7.4, to restore physiological pH, and incubated detect changes in the mobility of p220 BRCA1, prolonged 5 or 6% with 50 l of PBS/1% BSA/0.5% Tween-20 and 20 l of FITC-conju-SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was used gated anti-BrdU mAb (Becton-Dickenson), for 30 min at room tem-(e.g., 100 V for 16 hr). Transfer to nitrocellulose was performed using perature. After further washes, cells were incubated in 70 M propia semidry transfer method (Novablot, Pharmacia), in 50 mM Tris dium diiodide dissolved in 38 mM sodium citrate, in the presence base, 40 mM glycine, 0.37 g/l SDS, 20% methanol (for 3 hr at 1.5 of DNAase-free RNAase (2.5 g/ml final concentration, BoehringermA/cm2). After blocking with 5% nonfat dried milk in TBS-T (20 mM Mannheim) for 30 min at 37ЊC. Samples were analyzed immediately Tris, pH 8, 0.9% NaCl, 0.05% Tween 20) with sodium azide (0.1%), thereafter by FACS (Becton-Dickenson). the primary antibody, MS110 (Scully et al., 1996 ; Oncogene Science), was used at 2 g/ml in PBS/1% nonfat dried milk/0.1% azide, for Acknowledgments 1 hr at room temperature. The secondary antibody was peroxidaseconjugated goat anti-mouse IgG (HϩL, Jackson Immunoresearch),
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